G55393DZ
| Organisms | Evidence |
|---|---|
| Campylobacter jejuni |
RES 1b:a-dman-OCT-2:6|1:a|2:keto|3:d 2b:a-dgro-lman-HEP-1:5 3b:a-dgro-lman-HEP-1:5 4b:b-dglc-HEX-1:5 5b:b-dgal-HEX-1:5 6b:b-dgal-HEX-1:5 7s:n-acetyl 8b:b-dgal-HEX-1:5 9b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 10s:n-acetyl 11b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 12s:n-acetyl 13b:b-dglc-HEX-1:5 14s:phospho-ethanolamine LIN 1:1o(5+1)2d 2:2o(3+1)3d 3:3o(2+1)4d 4:3o(3+1)5d 5:5o(3+1)6d 6:6d(2+1)7n 7:6o(3+1)8d 8:8o(3+2)9d 9:9d(5+1)10n 10:9o(8+2)11d 11:11d(5+1)12n 12:2o(4+1)13d 13:2o(6+1)14n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 11854201 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients | Ang CW | 2002 Mar |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026